Wen Han

Wen Han is a Senior Scientist in Global Nucleic Acid Therapies at Novo Nordisk since July 2022, leading a screening team to optimize siRNA molecules and collaborating across functions to advance drug candidates from R&D to clinical stages. Prior experience includes roles as Scientist II and Scientist I at Dicerna Pharmaceuticals, focusing on siRNA drug candidate screening and lead optimization, as well as a Scientist in Cell and Molecular Biology at Hunter Biodiscovery, where Wen developed high-throughput screening platforms and supervised research associates. Academic qualifications include a PhD in Cell and Molecular Biology from Tulane University, during which Wen performed significant research on HER4 in breast cancer and served as a mentor and teaching assistant. A Bachelor of Science in Life Science was obtained from Nanjing Normal University.